Αρχική World News EMA Recommends Extension of Therapeutic Indications for Cetuximab World News EMA Recommends Extension of Therapeutic Indications for Cetuximab Από Ogkologos - 14 Αυγούστου, 2026 161 0 Facebook Twitter Google+ Pinterest WhatsApp New indications concern the treatment of adult patients with BRAF V600E-mutated mCRC in combination with encorafenib Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR 97-Year-Old Cancer Survivor Credits Her Success With Wanting To Attend A... 28 Οκτωβρίου, 2021 FDA Approves Carfilzomib and Daratumumab with Dexamethasone for Multiple Myeloma 24 Αυγούστου, 2020 Mom’s Topless Photo Is Supposed To Encourage Breastfeeding, But Some Think... 19 Μαρτίου, 2019 Higher Risk of Heart Failure Seen in Some Cancers 26 Μαρτίου, 2018 Φόρτωση περισσοτέρων HOT NEWS Adding Abiraterone to ADT and Docetaxel Improves Survival in Metastatic Prostate... Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause... Teen Gets Bullied After Series Of Drastic Growth Spurts, Now She... Five Questions With…Jae.
